NovaSom CEO and leadership

John T. Spitznagel is a Chief Executive Officer at NovaSom Inc and is based in Auburn, New York.

Michael Coppola is a Board Member at American Sleep Apnea Assn Inc, Exec VP:Medical Affairs/Chief Medical Ofcr at NovaSom Inc, and Associate Clinical Professor at Tufts University School of Medicine. He has worked as President/Chief Medical Ofcr at American Sleep Apnea Assn Inc and Vice Chairman at American Academy of Sleep Medicine (AASM). Michael works or has worked as MEMBER at Baycare Health Partners, BOARD MEMBER at Health New England Inc, and FELLOW at Organization of Chinese Americans Inc. He studied at Georgetown University School of Medicine.

Ernie Biczak is an Executive Vice President and COO at NovaSom Inc and Operating Partner at 1315 Capital Management LLC and is based in Glen Burnie, Maryland. He has worked as Vice President, Medical Affairs at Esprit Pharma; Vice President, Medical Affairs at ESP Pharma; and Vice President, Physician Practices at St Barnabas Healthcare System. Ernie studied at Rutgers Robert Wood Johnson Medical School between 1973 and 1977 and Rutgers University.

Mr. Stokes has 22 years of pharmaceutical and medical device experience, having worked in sales, marketing and business development. Prior to NovaSom, he served as Executive Vice President of Business Development at Oceana Therapeutics. Previous positions included President and Chief Operating Officer of Esprit Pharma, Inc., a specialty pharmaceutical company focusing in the genito-urinary therapeutic area, Vice President of Corporate Development for ESP Pharma, a specialty pharmaceutical company founded in 2002 to focus on the acute-care market, and Director of Business Development with Shire Plc.

Terry is a senior financial executive with more than 30 years professional experience, mainly in the healthcare services space. Terry has considerable experience as CFO of private equity portfolio companies, Prior to joining NovaSom, Terry was a Co-Founder and Chief Financial Officer at Alpine Health Ventures, a private duty home care company. Previous positions included Chief Financial Officer roles at Minsec, a behavioral health company, TargetRx, a data analytics company serving the pharma space, and Wolters Kluwer Health, a medical publisher. Terry started his career at KPMG in Philadelphia and is a CPA. Terry is a graduate of LaSalle University.

Mr. Stokes has 22 years of pharmaceutical and medical device experience, having worked in sales, marketing and business development. Prior to NovaSom, he served as Executive Vice President of Business Development at Oceana Therapeutics. Previous positions included President and Chief Operating Officer of Esprit Pharma, Inc., a specialty pharmaceutical company focusing in the genito-urinary therapeutic area, Vice President of Corporate Development for ESP Pharma, a specialty pharmaceutical company founded in 2002 to focus on the acute-care market, and Director of Business Development with Shire Plc.